Entera Bio Ltd. (ENTX) short interest & options flow
NASDAQEntera Bio heads into its November 13 earnings print with short interest at its highest level in months, an activist on the register, and a cluster of institutional buyers who entered at much higher prices. The short-selling pressure here is the most striking feature of the week. Short interest has jumped to 12.5% of the free float, up 18.5% over the past week and more than four…
ENTX short interest doubled in one week to 10.6% of free float, driven by activist accumulation and clinical momentum ahead of Phase 3 readout.
- Market cap
- $546M
- Next earnings
- 13 Nov 2026
Key data as of 9 Nov 2026
Latest signals on ENTX
- Short Interest
ENTX short interest doubled in one week to 10.6% of free float, driven by activist accumulation and clinical momentum ahead of Phase 3 readout.
2 Short Interest updates in 30 days
ENTX news and analysis
RSSNo long-form analysis yet for ENTX. Pulse alerts and the live data picture are available on ORTEX.
Open ENTX on ORTEX →Want the live picture for ENTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ENTX — free to start on ORTEX.
Sign up for free →Open ENTX on ORTEX